Kodiak Sciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KOD and other ETFs, options, and stocks.About KOD
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD.
KOD Key Statistics
Stock Snapshot
Kodiak Sciences(KOD) stock is priced at $27.41, giving the company a market capitalization of 1.56B. It carries a P/E multiple of -6.31.
On 2025-12-21, Kodiak Sciences(KOD) stock moved within a range of $25.64 to $28.00. With shares now at $27.41, the stock is trading +6.9% above its intraday low and -2.1% below the session's peak.
Trading volume for Kodiak Sciences(KOD) stock has reached 3.03M, versus its average volume of 1.07M.
Over the past 52 weeks, Kodiak Sciences(KOD) stock has traded between a high of $28.79 and a low of $1.92.
Over the past 52 weeks, Kodiak Sciences(KOD) stock has traded between a high of $28.79 and a low of $1.92.
KOD News
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
Kodiak Sciences Inc. recently filed and commenced an underwritten public offering of 6,000,000 shares of its common stock, with underwriters granted a 30-day op...
Kodiak Sciences (KOD) announced that it has commenced an underwritten public offering of 6M of shares of its common stock. J.P. Morgan, Jefferies, Evercore ISI...